Page last updated: 2024-08-25

suplatast tosilate and Bronchial Hyperreactivity

suplatast tosilate has been researched along with Bronchial Hyperreactivity in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (30.00)18.2507
2000's6 (60.00)29.6817
2010's1 (10.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, Y; Liu, D; Tan, Y; Zhong, L1
Aizawa, H; Fukuyama, S; Hara, N; Inoue, H; Komori, M; Koto, H; Matsumoto, K; Okamoto, M; Yoshida, M1
Aoshiba, K; Nagai, A; Nakata, J; Nishimura, K; Takeyama, K; Tamaoki, J1
Adachi, M; Ogawa, C; Ohta, K; Sano, Y; Suzuki, N; To, Y; Yamada, H1
Asada, K; Chida, K; Hashizume, H; Matsuda, H; Suda, T; Suzuki, K; Yokomura, K1
Adachi, M; Asano, K; Gonokami, Y; Kawazu, K; Konno, S; Kurokawa, M1
Kiniwa, M; Koda, A; Matsuura, N; Nagai, H; Ohwada, K; Taniguchi, H; Togawa, M1
Sano, Y1
Hamada, H; Hiwada, K; Kohno, N; Sakai, K; Yokoyama, A; Zhao, GD1
Banno, K; Hanazono, K; Handa, M; Horiguchi, T; Ishibashi, A; Kondo, R; Tachikawa, S1

Trials

2 trial(s) available for suplatast tosilate and Bronchial Hyperreactivity

ArticleYear
Effect of suplatast tosilate on airway hyperresponsiveness and inflammation in asthma patients.
    The Journal of asthma : official journal of the Association for the Care of Asthma, 2002, Volume: 39, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Anti-Allergic Agents; Arylsulfonates; Asthma; Blood Proteins; Bronchial Hyperreactivity; Eosinophil Granule Proteins; Eosinophils; Female; Forced Expiratory Volume; Humans; Inflammation; Japan; Leukocyte Count; Male; Middle Aged; Nitric Oxide; Respiratory Function Tests; Ribonucleases; Sulfonium Compounds; Treatment Outcome; Vital Capacity

2002
Effects of suplatast tosilate on airway inflammation and airway hyperresponsiveness.
    The Journal of asthma : official journal of the Association for the Care of Asthma, 2001, Volume: 38, Issue:4

    Topics: Adult; Aged; Anti-Allergic Agents; Arylsulfonates; Asthma; Blood Proteins; Bronchial Hyperreactivity; Eosinophil Granule Proteins; Eosinophilia; Female; Humans; Inflammation; Male; Middle Aged; Peak Expiratory Flow Rate; Ribonucleases; Sputum; Sulfonium Compounds

2001

Other Studies

8 other study(ies) available for suplatast tosilate and Bronchial Hyperreactivity

ArticleYear
Suplatast tosilate ameliorates airway hyperreactivity and inflammation through inhibition of the GATA‑3/IL‑5 signaling pathway in asthmatic rats.
    Molecular medicine reports, 2013, Volume: 8, Issue:1

    Topics: Airway Resistance; Animals; Arylsulfonates; Asthma; Bronchial Hyperreactivity; Disease Models, Animal; Eosinophils; GATA3 Transcription Factor; Histamine Antagonists; Inflammation; Interleukin-5; Leukocyte Count; Lung; Male; Ovalbumin; Rats; Signal Transduction; Sulfonium Compounds

2013
A TH2 cytokine inhibitor for airway inflammation in mild asthma.
    The Journal of allergy and clinical immunology, 2003, Volume: 111, Issue:1

    Topics: Arylsulfonates; Asthma; Bronchial Hyperreactivity; Cytokines; Sulfonium Compounds; Th2 Cells

2003
Effects of suplatast tosilate on allergic eosinophilic airway inflammation in patients with mild asthma.
    The Journal of allergy and clinical immunology, 2003, Volume: 111, Issue:5

    Topics: Adult; Aged; Anti-Allergic Agents; Arylsulfonates; Asthma; Bronchial Hyperreactivity; Case-Control Studies; Eosinophils; Female; Humans; Inflammation; Male; Middle Aged; Sulfonium Compounds; Th2 Cells

2003
Suplatast tosilate alters DC1/DC2 balance in peripheral blood in bronchial asthma.
    The Journal of asthma : official journal of the Association for the Care of Asthma, 2005, Volume: 42, Issue:7

    Topics: Adrenal Cortex Hormones; Aged; Anti-Allergic Agents; Antigen-Presenting Cells; Arylsulfonates; Asthma; Blood Cell Count; Bronchial Hyperreactivity; Dendritic Cells; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Forced Expiratory Volume; Health Services Accessibility; Histamine Antagonists; Humans; Male; Middle Aged; Sulfonium Compounds; Treatment Outcome

2005
Effect of IPD-1151T (Suplatast Tosilate) on airway hyperresponsiveness in mice.
    Arerugi = [Allergy], 1995, Volume: 44, Issue:5

    Topics: Administration, Oral; Animals; Arylsulfonates; Bronchial Hyperreactivity; Bronchoconstriction; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred BALB C; Sulfonium Compounds

1995
Suplatast tosilate, a new type of antiallergic agent, prevents the expression of airway hyperresponsiveness in guinea pigs.
    European journal of pharmacology, 1996, Dec-30, Volume: 318, Issue:2-3

    Topics: Animals; Anti-Allergic Agents; Arylsulfonates; Bronchial Hyperreactivity; CD4-Positive T-Lymphocytes; Eosinophils; Guinea Pigs; Interleukin-5; Ketotifen; Male; Sulfonium Compounds

1996
[Anti-inflammatory drugs for the treatment of bronchial hyperresponsiveness].
    Nihon Kyobu Shikkan Gakkai zasshi, 1996, Volume: 34 Suppl

    Topics: Administration, Inhalation; Administration, Oral; Adult; Aged; Anti-Allergic Agents; Anti-Inflammatory Agents; Arylsulfonates; Asthma; Beclomethasone; Bronchial Hyperreactivity; Female; Humans; Male; Middle Aged; Sulfonium Compounds

1996
Effect of suplatast tosilate (IPD-1151T) on a mouse model of asthma: inhibition of eosinophilic inflammation and bronchial hyperresponsiveness.
    International archives of allergy and immunology, 2000, Volume: 121, Issue:2

    Topics: Animals; Anti-Allergic Agents; Arylsulfonates; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchoalveolar Lavage Fluid; Cytokines; Disease Models, Animal; Eosinophilia; Female; Immunoglobulin E; Immunoglobulin G; Lung; Methacholine Chloride; Mice; Ovalbumin; Sulfonium Compounds

2000